| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $28.9350 | +4.53% | $1.74B | $133.66K | |
SGRY Surgery Partners, Inc. Common Stock | $13.7950 | +2.11% | $1.74B | $379.73K | |
GAB The Gabelli Equity Trust Inc. | $5.5950 | -0.27% | $1.74B | $555.60K | |
HURN Huron Consulting Group Inc. | $107.69 | +2.75% | $1.74B | $25.11K | |
ENVX Enovix Corporation Common Stock | $8.3050 | +0.91% | $1.74B | $2.89M | |
PAYO Payoneer Global Inc. Common Stock | $5.2050 | +2.26% | $1.74B | $1.10M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14.9200 | +0.07% | $1.73B | $66.39K | |
STGW Stagwell Inc. Class A Common Stock | $6.7350 | +2.20% | $1.73B | $309.77K | |
CASH Pathward Financial, Inc. Common Stock | $78.5400 | +1.03% | $1.73B | $58.74K | |
SNDX Syndax Pharmaceuticals, Inc. | $17.9210 | -2.28% | $1.73B | $4.48M | |
STRA Strategic Education, Inc. Common Stock | $81.5350 | +3.14% | $1.73B | $67.72K | |
CAPR Capricor Therapeutics Inc | $28.3730 | +2.65% | $1.73B | $213.27K | |
AAPG Ascentage Pharma Group International American Depository Shares | $18.4210 | +3.08% | $1.73B | $1.72K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $8.8650 | +8.24% | $1.73B | $3.49M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $27.5450 | +10.22% | $1.73B | $279.86K | |
